The realization that many persons with HIV/AIDS are subjected to multiple layers of stigmatization because they belong to socially deviant and disenfranchised groups (e.g., injection drug users, racial/ethnic and sexual minorities) accounts for an increasing interest in the phenomenon of stigma layering. The stigma associated with hepatitis C virus (HCV) has also been conceptualized as layered. However, researchers have overlooked the fact that HCV adds a layer to the HIV stigma and vice versa. Qualitative interviews with 132 HIV/HCV-coinfected patients were analyzed to explore how they experience the two layers of stigma. Most participants hierarchically ordered the stigmas associated with each disease and regarded HIV as the more stigmatizing of the two. A small number perceived HIV and HCV as equally stigmatizing. The impact of the hierarchical and nonhierarchical ordering of the two stigmas on coinfected patients' felt and enacted stigmatization is explored and implications for interventions are discussed.
Despite treatment advances that have transformed HIV/ AIDS into a less deadly, more manageable chronic disease, it remains highly stigmatizing and contributes to the social marginalization of those infected, thus undermining their mental and physical well-being (Logie & Gadalla, 2009; Ware, Wyatt, & Tugenberg, 2006) . In the United States, public education campaigns and programs aimed at destigmatizing HIV/AIDS notwithstanding, the uninfected continue to harbor misconceptions about the disease and irrational fears of contagion, as well as blame those infected for acquiring HIV through socially and morally irresponsible sexual and drug-using behaviors (Brodie, Hamel, Deane, & Gutierrez, 2006) . In attempting to account for the persistent nature of HIV stigma, researchers have focused on the cooccurrence of multiple stigmas assigned to the social groups typically infected with the disease, a phenomenon that has been called stigma layering (Reidpath & Chan, 2005) .
More than a decade ago, Novick (1997) referred to the "peculiarly stigma-sensitive epidemiology of HIV" (p. 54), and suggested that most persons who became infected had been exposed to stigma and discrimination prior to their HIV diagnosis because of their being homosexual, bisexual, a racial/ethnic minority, poor, a drug user, or a sex worker. An HIV-positive diagnosis conferred on these social groups one more stigmatizing attribute that justified further disenfranchising and "layering upon them more disdain and punishment" (Novick, p. 60) . The recognition that persons living with HIV/AIDS (PLWHA) confront multiple stigmas because of their sexual and racial/ ethnic minority status, low socioeconomic status, and engagement in drug use and sex work that systematically relegate them to the margins of society underlies the recent research on the layering of HIV stigma. Recognition of the layered nature of HIV stigma has also prompted researchers to revisit the ways it has been conceptualized (Parker & Aggleton, 2003) . A characteristic of the stigma literature, including the literature on HIV stigma, is the lack of a clear definition of the concept (Link & Phelan, 2001) . Researchers tend to assume either the dictionary's definition as a mark of shame or discredit, or a version of Goffman's definition of stigma as an "undesirable difference" that undermines a person's identity (Goffman, 1963) . Moreover, although Goffman understood stigma as the outcome of the "relationship Qualitative Health Research 21(9) between attribute and stereotype" (Goffman, p. 4 ), most researchers have not used his language of relationships and instead have viewed stigma as an individual attribute that is by default socially undesirable. Therefore, researchers have tended to disregard the role of others, individuals or social groups, in linking an attribute to a negative stereotype and actively discriminating against its carriers (Link & Phelan) . This conceptualization obscures the delineation between sources and targets of stigmatization, and fails to differentiate between felt and enacted stigma. It also prohibits the realization that the sources and the targets of stigmatization are socially situated, that enacted stigma is a means of producing and reproducing the existing social hierarchies, and that resisting or negotiating the experience of felt stigma is a means of challenging these hierarchies (Parker & Aggleton, 2003) . The distinction between felt and enacted stigma that enables the targets of stigmatization to provide a situated account of their experience of having multiple stigmatizing statuses, although essential for understanding stigma layering, has been largely overlooked. In this analysis, we use the term enacted stigma to refer to "episodes of discrimination against" those with a stigmatizing attribute, and the term felt stigma to refer to the shame associated with having this attribute and/or "the fear of encountering enacted stigma" (Scambler, 2004, p. 33) . Below, we organize the literature on HIV and hepatitis C virus (HCV) stigma layering using the concepts of felt and enacted stigma.
A few researchers have measured the stigmatizing attitudes of the public and health care providers toward PLWHA, and have tried to disentangle the extent of stigma evoked by their HIV status from the stigma evoked by other discrediting statuses, such as injecting drug use, bisexuality, sex work, and mental illness, that often accompany those infected (Chan, Stoové, Sringernyuang, & Reidpath, 2008; Reidpath & Chan, 2005; Walkup, Cramer, & Yeras, 2004 ). Walkup and colleagues, using vignettes to control for the two statuses of having HIV and severe mental illness, demonstrated that undergraduate college students had less stigmatizing attitudes (expressed in terms of social distancing) toward PLWHA compared to attitudes toward those with severe mental illness. The vignette depicting a person diagnosed with both conditions elicited the highest stigmatization, thus leading to the conclusion that the layering of the two stigmas had an additive effect on the students' stigmatizing reactions. Similarly, vignettes of injecting drug users (IDUs) elicited the strongest stigmatization from nursing students in Thailand, followed by vignettes of persons with AIDS, and finally of those engaging in commercial sex (CS; Chan et al., 2008) . The researchers concluded that "the double stigma of IDU and AIDS was far more stigmatizing than the double stigma of AIDS and CS or AIDS on its own," and called for future studies to explore "the relevant impact of co-stigmas" (Chan et al., p. 154 ) on the public's discrediting reactions and the lives of PLWHA. Both studies addressed tendencies of the uninfected to enact stigma through social distancing. Therefore, the finding that multiple stigma layers had an additive effect on enacted stigma cannot be automatically applied to felt stigma.
Recently, researchers have endeavored to measure PLWHA's felt stigma elicited by different stigmatizing statuses, and used the concept of HIV stigma layering to interpret their findings. Most analyzed how racial/ethnic minority status and gender interface with HIV stigma, and indicated that how PLWHA perceived and felt about stigma differed by these two variables (Bogart et al., 2007; Rao, Pryor, Gaddist, & Mayer, 2008; Wolitski, Pals, Kidder, Courtenay-Quirk, & Holtgrave, 2008) . Rao and colleagues found that Black PLWHA endorsed as most salient the items on the HIV stigma scale that referred to being socially discriminated and morally judged, whereas their White counterparts endorsed items related to interpersonal rejection and concealment of their HIV status. In interpreting these race-related differences in stigma experiences, the researchers referred to the multiple stigmas confronting Black PLWHA as a result of racial and social class discrimination. Wolitski and colleagues indicated that homelessness and low educational attainment, characteristics that also confer stigma, along with female gender, heightened the sense of shame and fear of being discriminated among PLWHA, a finding the researchers linked to HIV stigma layering. Bogart and her colleagues (2007) , in a qualitative study of PLWHA and their families, concluded that being a woman of a racial/ethnic minority background, a man who has sex with men, or an injection drug user "compounded" a person's felt stigma. The researchers also used the concept of "multiple layers of HIV stigma" to account for their participants' varied stigma experiences. Similarly, in our study of African American, Puerto Rican, and White women living with HIV/AIDS, we found that participants from the first two groups associated their feelings of shame to society's stereotypical view of PLWHA as non-White, and feared being discriminated against by society. White participants felt ashamed for being outliers in their own racial community and in the HIV community, and feared being discriminated against by these two communities (Lekas, Siegel, & Schrimshaw, 2006 ). In the same study, women across racial/ethnic groups agreed that society tended to blame and discriminate against them more than men for engaging in the same sexual and drug-using risk behaviors. This realization, however, did not always intensify the women's felt stigma.
The studies cited above revealed that having multiple stigmatizing statuses influenced a persons' exposure to enacted stigma and shaped his or her experiences of felt stigma. We propose, however, that assuming an additive or compounding effect on the felt stigma experienced by persons exposed to multiple layers of stigma might be premature or even misleading. A recent literature review on HIV stigma layering confirmed that the stigmas of female gender, racial/ethnic minority status, and young age account for why "AIDS-related stigma is experienced differently by people with additional stigmatized identities" (Henkel, Brown, & Kalichman, 2008 , p. 1596 , and emphasized the need to better understand stigma layering.
Coinfection with hepatitis C virus is another socially devalued characteristic common among persons infected with HIV that has been overlooked in studies on HIV stigma. In the United States, approximately 33% of persons infected with HIV are also infected with HCV (Sulkowski, 2008) , and among HIV-infected injection drug users this rate ranges from 50% to 90% (Centers for Disease Control and Prevention, 2004) . Although HCV infection is typically the result of injecting drug use, a highly stigmatizing behavior that has been defined as one of the layers of HIV stigma, there is very limited research on the two stigmas associated with being coinfected with HIV and HCV. We found only one qualitative pilot study of six gay-identified coinfected men in the United Kingdom (Owen, 2008) . The author reported that, in the gay community, HCV is more stigmatizing than HIV because of its association with injecting drugs. HIV, as a factor that might compound HCV stigma, was also mentioned in a recent literature review on HCV stigma, and the author recognized that the stigmas of both diseases are shaped by their association with "devalued social groups" (Butt, 2008, p. 712) .
The impact of HCV stigma on both those infected and the attitudes of health care practitioners who treat this population has been the focus of several studies. Persons with HCV have identified stigma as a significant challenge that undermined their quality of life (Strauss & Teixeira 2006) , mental well-being, and adjustment to their illness (Crockett & Gifford, 2004; Golden, Conroy, O'Dwyer, Golden, & Hardouin, 2006) . At the root of HCV stigma is its association with injecting drug use (Conrad, Garrett, Cooksley, Dunne, & Macdonald, 2006; Crocket & Gifford; Golden et al.) . Golden and colleagues indicated that in a clinic sample awaiting treatment for HCV in Ireland, the highest stigma scores were reported by patients whose infection was attributed to injecting drugs, whereas the lowest scores were reported by those with an unknown etiology. The researchers attributed the heightened sense of stigma of those infected through drug use to the "double stigma of an infectious disease associated with behavior perceived as socially deviant" (Golden et al., p. 3196) . Qualitative data from HCV-infected persons in Australia also suggested that their feelings of stigma stemmed from the association of the disease to injecting drug use (Conrad et al.) . In the same study, an additional source of stigma was the fear of contagion, stemming from the lack of understanding of the disease among both the public and those infected. Similarly, an HCV-infected sample of women in Australia linked their feelings of shame and sense of being tainted to their concerns about HCV transmission (both casual and sexual), and witnessing their families' and partners' "conspicuous fear of contracting the virus" (Crocket & Gifford, p. 124) . Perceiving their health care providers as lacking an understanding of the disease further eroded these women's own understanding of their HCV and sense of self.
A recent literature review revealed that HCV-infected persons attributed their experiences of felt and enacted stigma to their health care providers' negative views of injection drug use and lack of understanding both of this behavior and of the disease (Paterson, Backmund, Hirsch, & Yim, 2007) . The authors of the review hinted at the phenomenon of HCV stigma layering by stating that "hepatitis C-related stigma is multifaceted," complicated by the stigmas of "illicit drug use, poverty, ethnicity, homelessness, and prostitution," and identified the lack of research on how HCV stigma differs by these negative attributes as a major limitation of the literature (Paterson et al., p. 369) . Coinfection with HIV, another disease with layered stigma, is a conspicuous omission from this list of discrediting statuses that effect HCV-related felt and enacted stigma.
In this article, we explore the impact of the layered stigmas of HIV and HCV on the experiences of felt and enacted stigma among former and current injecting drug users coinfected with both diseases. Most participants' accounts revealed an interaction effect between the two diseases' stigmas. Fewer participants described an additive effect between the two stigmas. With this analysis on how persons contend with the stigmas of being coinfected with HIV and HCV, we intend to contribute to our understanding of the phenomenon of stigma layering as experienced by socially situated targets of stigmatization.
Methods Sample
The present analysis is based on in-depth interview data from 132 HIV/HCV-coinfected men and women participating in a New York City-based qualitative study about their adaptation to living with these two serious chronic illnesses. To be eligible for study participation, a person had to meet the following criteria: (a) be a current or past injecting drug user; (b) be both HIV-infected and have chronic hepatitis C, and have been notified of these results by a health care provider; (c) not have chronic hepatitis B infection; (d) be at least 18 years of age; and (e) be African American or Puerto Rican (born in the United States or Puerto Rico). This last criterion was imposed to reflect, first, the coinfection epidemic that has afflicted predominantly African American and Hispanic injection drug users (Strader, 2005) , and second, the racial/ ethnic make-up of the patient population in the two AIDS clinics that served as the study's recruitment sites, where 93% of the coinfected patients were African American and Puerto Rican (with Puerto Ricans representing 75% of the Hispanic patients).
The participants ranged in age from 30 to 69 years, with a mean age of 49.9 years. The majority were men (69%, vs. 31% women) and Puerto Rican (64%, vs. 36% African American). Eighty-nine percent of participants identified as heterosexual. The sample was quite socioeconomically disadvantaged, reflecting their long engagement with injecting drug use. Forty-three percent had not graduated from high school, 80% were not working, and approximately half (49%) earned less than $10,000 annually. Eighty-eight percent indicated that they had not injected drugs in the previous year. In terms of their health status, more than half (53%) had an AIDS diagnosis, and 77% were on HIV treatment at the time of interview. More than one fourth (27%) had been on HCV therapy at least once since their diagnosis, and 11% were diagnosed with cirrhosis of the liver.
Recruitment
To identify and enroll eligible cases, every week two case identifiers-staff members of the two large public AIDS clinics collaborating with the study-reviewed the medical records of patients scheduled for upcoming clinic appointments. On the day of their appointment, potentially eligible patients were approached in the waiting area by the case identifier and asked to come to a private office. This process ensured that identified patients would not be recognized by others in the waiting room as prospective study participants, and therefore as HCV infected. In the office, the case identifier explained the purpose of the study and prescreened the patients to ensure they were aware of their coinfected status. Interested patients were directed to the study's private office, where a study interviewer provided further information about the study and screened for eligibility. Those eligible and wishing to participate scheduled an appointment with the interviewer. The institutional review boards of the authors' university and of the two affiliated AIDS clinics approved the study and its procedures.
Data Collection
All data were collected from July 2004 to March 2006 by three women interviewers, two Latina and one White non-Hispanic; the last is also the first author (Lekas) .
More than one third of the Puerto Rican participants (38.8%) were interviewed in Spanish. The interviews took place in a private office dedicated to the study and located in each AIDS clinic, thus increasing convenience and facilitating participation.
The interview consisted of two sessions (each lasting approximately 2 hours) that most participants (89%) elected to complete on the same day, with a break for lunch. Prior to the interview, participants read and signed the informed consent and Health Insurance Portability and Accountability Act (HIPAA) forms, to ensure the confidentiality of the data patients provided in the context of the study, and safeguard the privacy of their personal health information. Next, the interviewer administered a brief questionnaire that elicited standard sociodemographic and health data, including information on sexual risk behavior, current and past drug/alcohol use, and experience with HIV and/ or HCV treatment. The session continued with participants completing a small set of self-administered measures assessing psychological distress and well-being, quality of life, and coping strategies. Following completion of these measures, the remainder of the interview (150 to 170 minutes) was dedicated to the qualitative interview. Participants received a $25 honorarium per session ($50 for completing the full interview), and were reimbursed for all transportation and child care costs.
An interview guide was used to direct the qualitative interview. The guide focused primarily on the adaptational challenges facing patients coinfected with two serious and contagious diseases, and the coping strategies they employed. Based on preliminary data analysis, we identified (a) the participants' extensive lack of knowledge regarding HCV and its treatment, (b) their reluctance to discuss the impact of being HCV infected on their health, and (c) rich and complicated experience as long-term injecting drug users. These insights resulted in revising the guide to better elicit data on all three of these areas in the participants' lives. The main domains covered in the guide were the following: symptom interpretation and management, treatment decision making and adherence, becoming informed about each disease and its modes of transmission, disclosure of each status, experiences of felt and enacted stigma related to HIV and/or HCV, contending with the impact of their coinfection on their well-being and quality of life, and satisfaction with medical and social services.
To elicit data on felt and enacted stigma and their impact on a participant's identity, if these issues did not emerge organically during the interview, we asked the following questions separately for each disease: (a) What beliefs and opinions do you think people who are not HIV or HCV positive have about those who are? (b) Do you ever feel that people who are not HIV or HCV positive judge you in any way for being HIV or HCV positive? (c) Was there ever a time when you felt that people reacted to you or treated you differently because you are HIV or HCV positive? and (d) Has how you feel about yourself changed in any way as a result of being HIV or HCV positive? Stigma experiences were discussed throughout the interview, and we estimate that these discussions lasted approximately 15 to 25 minutes. The present analysis is based primarily on data related to these stigma questions, supplemented by insights from the whole interview.
Qualitative Data Analysis
All qualitative interviews were audio-recorded and transcribed verbatim for analysis. To define codes for organizing the data, the first and second authors (Lekas and Siegel) read approximately half of the transcripts multiple times to become familiar with the content of the interviews, including participants' interpretations of the challenges of coinfection covered in the guide and any unanticipated issues that emerged in their accounts. While reading the transcripts, it became apparent that the construction of a coding scheme was impeded by the types of accounts participants provided. Specifically, their accounts of contending with both diseases tended to be exceptionally fragmented and meandering (i.e., nonlinear). When the interviewer raised issues participants had not previously thought about, many would initially provide a short and simple response, but later in the interview they would return to these same issues and provide a more comprehensive response. In this manner the participant compared the two diseases and discussed their differences and similarities throughout the interview. Three participant characteristics appear to have fostered this response style: first, their lack of knowledge regarding HCV in comparison to HIV; second, their ambivalence toward contending with being coinfected; and third, their long-term drug use that contributed to disjointed cognitive patterns. Consequently, we recognized that coding the transcripts and extracting blocks of text under specific codes and subcodes would overfragment the data, compromising their interpretation. Therefore, a decision was made to develop analytic profiles for each case that would allow for a more comprehensive and complete presentation of the data.
The first and second authors each read a different set of 25 interviews and independently decided on the main domains that should be included in the analytic profile. Next, we discussed and jointly defined those domains that closely reflected the interview guide domains. We decided that under each domain the relevant data would be extracted and a summary of these data composed. All profiles were finally constructed by four researchers: two were interviewers for the study, and thus intimately familiar with the data, and two were previously uninvolved with the study and provided a fresh perspective on the data.
The first author trained these four researchers in the creation of the profiles, and ensured quality control through random checking of profiles, training meetings to discuss the data and process, and periodically assigning to all four researchers the same case, thus assessing reliability of the profiles. The creation of each profile began with reading the whole interview transcript, then synthesizing and organizing all the relevant data under the main domains addressed in the interview. Second, based on the data excerpted that substantiated their observations and inferences about different aspects of each domain, the researchers wrote interpretative summaries for each domain in every profile. Constructing these summaries and identifying data to support their interpretations promoted the analysis by leading to further decisions about creating or splitting a domain, or analytically linking various domains. For instance, the domain of disclosure was divided into two domains: disclosure to family and friends that was analytically linked to the stigma domain, and disclosure to sexual and drug-using partners that was analytically linked to the risk behavior domain. The following findings are based primarily on the data under the "stigma" domain, supplemented by data under the "disclosure to family and friends" domain. After completion of all profiles, the first and second authors identified analytic patterns across all cases.
Findings
The primary finding was that most participants compared the stigmas from the two diseases, hierarchically ordered them, and perceived their HIV status as more stigmatizing than their HCV status. Some participants diverged from this pattern and viewed HIV and HCV as equally stigmatizing.
HIV Is More Stigmatizing Than HCV
Most participants reported experiencing some felt stigma for being HCV infected, associated with the disease's contagious nature. However, their feelings of stigmatization because of their HIV status were more intense and far reaching for several reasons. Specifically, the societal stereotypes associated with an HIV-infected person, the perception of HIV as a deadly disease, and the enacted HIV stigma participants had experienced, resulted in their viewing the HIV stigma as more pervasive and detrimental to their well-being and lives compared to the HCV stigma.
Societal features of HIV/embodied features of HCV. Participants discussed extensively the highly derogatory stereotypes society has constructed for persons with HIV/ AIDS, and the public's conviction that infected individuals are drug users, sex workers, homosexuals, and/or sexually promiscuous. All of these behaviors, participants claimed, are viewed by society as illegal or morally reprehensible and undesirable. Therefore, persons with HIV are classified as blameworthy, undeserving of compassion, and targets of unrelenting stigmatization. Many participants internalized these stereotypes, and attributed their feelings of shame, worthlessness, and being tainted primarily to their HIV status. The association of HIV with drug use and the "street life" was especially salient for most participants, and significant, given that the sample consisted exclusively of long-term injecting drug users who typify this stereotype. A 51-year-old Puerto Rican man associated his intense feelings of stigma with the HIV-related stereotypes:
Already, like if you are HIV, already you cannot make more children, meaning, it has like a, a stigma more, a little bit more . . . it [HIV] has a stigma that for me is too strong. . . . Well, I have heard some say that you are homosexual, they have it because they are homosexual, like he has it because like, or, because he is an addict, or that one because, she got [HIV] because she was having too many men or something like that, or [had sex with] women [sex workers]; those are the comments.
The participant contended that, in contrast to HIV, society does not have a negative stereotype for persons with HCV: "[There is no] mention [by the public], no, you know, about the hepatitis C." In discussing the stigma related to HCV, he focused on this disease's modes of transmission, and expressed concern about infecting his family, but denied feeling ashamed: In comparing others' attitudes toward the two diseases, the quoted participant suggested that HCV does not carry the same opprobrium as HIV: "[For an HIV-positive person, others will say] he has the monster, you know, he has these and that, you know, like, 'Be careful.' This is not said to a person with hepatitis." Other participants also indicated that the disparaging term monster is reserved solely for HIV. This supported their belief that HCV is less stigmatizing, and justified their feeling less or no shame for being HCV positive. The term monster was used in the stigma accounts of both African American and Puerto Rican participants, including those who were interviewed in Spanish, suggesting that this demeaning term or "illness slur" (Lekas et al., 2006) is not culturally specific. For instance, a 53-year-old African American woman who claimed that the HIV-related stigma is stronger than that for HCV, referred to the same term when describing her experience of vicarious stigmatization:
I had a conversation with a lady that didn't know that I was HIV positive. And everything that came out of her mouth was negative about a person with the virus. "Oh, they nasty, um, they probably was crack head," or, "They're living with that monster." And all the time she was saying it, I was just gritting my teeth. Gritting my teeth. And finally, when she finished just saying what she had to say, I said, "You know what? Well, I'm one of those persons."
The participant viewed HCV as a biological agent that caused a physical illness that, unlike HIV, did not carry any negative connotations about the infected person's character. This difference between the two diseases also accounted for why her HIV serostatus undermined her mental well-being and self-worth, whereas she considered HCV as a disease she could manage:
The hepatitis C, I can deal with. . . . Because to me, I'm living, that hepatitis C as a, just, just a fungus. Or a bacteria, where, the HIV virus is more in depth. You know, as far as, um, the disease itself. Because it just takes a toll on you mentally, [participant choked up] physically. Um, it just turns your whole life around. You know, because, I mean, there are so many aspects of your life. Who wants, no one accepts rejection. . . . I know I'm worthy. I'm a worthy person, but sometimes I feel worthless [because of my HIV status].
Many participants shared the belief expressed above that becoming infected with HIV damaged their sense of self, primarily because it implied a moral failing. Garbage, piece of trash, nobody, and outcast were terms used to describe how they felt as a result of internalized HIV stigma, and very infrequently HCV stigma. In an attempt to salvage their discredited self, several participants tried to differentiate themselves from the stereotypical PLWHA. Specifically, those who indicated that they got infected through injecting drug use emphasized that they did not routinely share their needles and other drug use paraphernalia, did not frequent "shooting galleries," or were not sexually promiscuous, and attributed their infection to exceptional circumstances. Those who claimed to have become sexually infected with HIV highlighted their infrequent drug use. These accounts of how participants became infected, designed to decrease the moral blemish on their character, were provided primarily for HIV, not HCV. For instance, a 54-year-old African American woman who did not fear any rejection for having HCV because she agreed with society that it is "no big deal," explained to her family that she became infected with HIV sexually, thus attempting to provide a less blameworthy account:
I guess it's because of how you may develop [HIV], but they [her family] know that I was not, no, um, IV-drug user, so there was, there's no need for them to um, uh, to, to withdraw from me the way they do. Um, I told them it was unsafe sex; I have no reason to lie about it. . . . That's why I keep it to myself about HIV, because people are out of their mind. They are very, you know, it's like I'm a piece of trash because I have HIV.
In contrast to HIV, most participants discussed HCV as just another illness instead of a moral failing. Perceiving HCV as a physical illness normalized it to some extent, and decreased or even eliminated participants' felt stigma. For instance, a 41-year-old African American woman indicated that having hepatitis C is less likely to evoke rejection, and might even elicit compassion from others because it is viewed as a true illness:
[Others think about those with HIV], that they is a freak, oh they think they must be bad. You know, like they not know the deal . . . you would have to have sex with like a trick [as sex worker], or you were going to have an affair with somebody, you know, or you know it's, 'less they get high. You know and I know that I'm a good person, but everybody don't. . . . I think people have different opinions about people who have hep [hepatitis] C, because you know that's uh, that's not like uh catching AIDS. It's, they're maybe more compassionate there, they are more, you know, more interaction, rather than when they are finding out you have AIDS. . . . So you have, people don't have to look at the homosexuals like, y'all brought these diseases to you, you know. But see, like the hep C, it's like a, a, a genuine disease.
In the following quote, a 50-year-old Puerto Rican man defined hepatitis C as a "malfunction of the liver," and referred to the numerous ways the disease can be transmitted, when explaining why HCV elicits less "harsh" reactions than HIV:
It's not as harsh as, as HIV, um, but from my experience, it hasn't been as harsh. I guess they figure you get hepatitis from-most people are not that educated on hepatitis, like I wasn't. Uh, so you think hepatitis is just a malfunction of the liver, or you know, you got it in the hospital, or you got cut, or, you know, um, but HIV has been associated with gay people and drug users. . . . No [others do not look down upon those with HCV].
Claiming that HCV is a "genuine disease," or "a malfunction of the liver," called attention to its physical (i.e., embodied) instead of its social features, thus deflecting social stigmatization. In addition, referring to the multiple ways in which HCV can be transmitted, and emphasizing the blameless ways of acquiring the disease (e.g., nosocomially or through a wound), divorced the disease from its association with discrediting sexual and drug-using behaviors, thus further decreasing its stigmatizing potency. Therefore, conceptualizing HCV as a physical illness that can be transmitted in a variety of ways seemed to diminish its stigma, especially in comparison to HIV, and assuage participants' feelings of shame. As a 40-year-old Puerto Rican man explained, HCV is in the lower ranks of the stigma hierarchy, "because nobody talks about it. Because it's, it's not up there. It's a vaccine, something you catch from fish or tainted meat, you know, nobody knows."
HIV is perceived as more deadly than HCV, and therefore is more stigmatizing. The hierarchical ordering of the two stigmas was also influenced by the participants' and the public's perceptions of the mortality and associated dread of each disease. Several participants viewed HIV as a more deadly disease than hepatitis C, and thus felt more stigmatized for being HIV positive. Some evoked the severity of HIV, whereas others focused on the potentially curable nature of HCV when discussing the stigma conferred by having each disease. For instance, the belief that HCV is curable minimized the stigma a 49-year-old Puerto Rican man felt for having this disease. His HIV serostatus made him feel like an "outcast," whereas his HCV serostatus was far less distressing: I'm more, I was more focused on the virus, on the HIV virus, the hepatitis C didn't really bother me too much because after speaking to the doctors, the doctor explained to me that, you know, with treatment, you know if I get treatment it's a 50-50 chance that you know, we get rid of that altogether, and the virus, I never heard that about the virus. The virus Qualitative Health Research 21 (9) is here, it's here, it's here, it ain't going nowhere. I can never suppress it, bring it under submission, you know. This participant, similar to others who perceived HIV as the more stigmatizing illness of the two, used the term virus only for HIV, not HCV.
Another participant, a 57-year-old African American man who clearly perceived his HCV as less stigmatizing than his HIV, highlighted the fact that the public is well aware that HIV is a fatal disease. Although he was recently told by his medical provider that he had to undergo treatment for his HCV, he continued to perceive it as a less severe disease:
[People with HCV are not rejected]. No, not like people who have HIV, no. Well, I think, because people, they, they think they know a little more about HIV and the outcome is death, of course, and they don't see hep C probably like I do, as something that can kill you, you know. . . . [he explained why he had not disclosed his HCV to his family]. I haven't really spoken about it because I never really took it that serious, you know. Until here recently and um, and I still don't look at hep C as being as serious as HIV, you know.
The impact of HIV hygienic degradation rituals on HCV felt stigma. The third reason why most participants regarded their HIV as more stigmatizing than their HCV was their exposure to interpersonal, everyday acts of discrimination after disclosing their HIV diagnosis to family and friends. Specifically, the majority of participants were diagnosed with HIV several years prior to their HCV diagnosis. Thus, many had disclosed their HIV status to friends and family, and had contended with HIV stigmatization prior to confronting even the prospect of HCV stigma. Moreover, many had disclosed their HIV status to others in the early-to mid-1990s; some even in the 1980s, when the disease was highly fatal, poorly understood, and elicited intensely fearful and stigmatizing reactions. The most frequent form of enacted stigmatization consisted of what we have called "hygienic degradation rituals" (Lekas et al., 2006) ; that is, the adoption by uninfected persons of excessive, often gratuitous precautions to avoid becoming infected with HIV through casual contact with the person who has the disease. Many participants indicated that their families viewed them as vectors of HIV infection, and engaged in these hurtful hygienic rituals. Designating particular plates and utensils for the participants' sole use, constantly disinfecting the bathrooms, refraining from kissing them, and even barring participants from interacting with the family's children, were experienced as degradation rituals. In many cases, exposure to such rituals resulted in intense HIV felt stigma, anticipation of being subjected to similar HCV degradation rituals, and concealment of their HCV status, and therefore generated some HCV felt stigma. For example, a 33-year-old Puerto Rican woman referred to her family's unfounded fears of infecting her son with HIV when describing her feelings of shame and the decision to conceal her HCV serostatus from her relatives: Her disclosure of her HIV status to her family was an attempt to gauge their fears of contagion, and protect herself from her relatives' degradation rituals:
[I told them about the HIV]. Because I visit them. I'm in they [their] household. You either want me there or you don't. You understand, 'cause I don't want to be served on paper plates and all that stuff. I want to know where you at with me. Not where I'm at with you. You understand, so either-either they going to shy away and treat me different-that means that part of the family-I don't mess with.
She also explained that she had concealed her HCV status from her family because of its contagious nature: "No [I haven't told my family about the HCV], 'cause they know that hepatitis C is very contagious, right?"
Although most degradation rituals were enacted by family, some participants reported being subjected to such rituals by close friends-an equally hurtful and distressing experience. A 42-year-old Puerto Rican man attributed his decision to end a friendship to being treated in a manner that exaggerated his contagious status. This experience convinced him to conceal his HCV status from other friends:
[I did not tell them about my HCV]. Because, they're-again, they're going to think they're going to catch something from me breathing on them or something. Yeah, [I felt] that I would be rejected by them, yeah. I had a friend that actually, he found out I was [HIV] positive. I went to his house, and every time I went there, he would have a special glass just for me, and that really like, it tore me up, and I just stopped being friends with him because of that. Oh, yeah, we spoke on it. It was just, I guess he wasn't educated enough on the, you know, about the HIV, that it was, that's just the way he thought: that you catch it by touching, by eating with someone's fork or drinking out of someone's glass. So, that caused us not to become friends. We just broke up our friendship.
As the quotations above revealed, the HIV-related degradation rituals participants experienced resulted in their regarding HIV as more stigmatizing than HCV. However, these same degrading experiences partly generated their HCV felt stigma, and accounted for their decision to conceal their HCV status. This decision, as we discuss next, was associated with the perception of HCV as a highly contagious disease.
Perception of HCV as a contagious disease. Accounts of HCV stigma tended to focus on the multiple modes of transmission of this disease and the fears of contagion participants and others harbored. The participants' illness representation of hepatitis C as a highly contagious disease that can be passed through casual contact constituted the primary source of HCV-related felt stigma. In addition to the degrading rituals related to their HIV, two other factors amplified participants' concern about being contagious and fears of being treated by others as untouchable: the public's ignorance about HCV, and the participants' own ignorance about the disease.
The public's ignorance about HCV. Participants believed that most people do not know how HCV is transmitted, and therefore are inclined to excessively fear the disease and ostracize those infected. The terms uneducated and ignorant were repeatedly used to describe the public's lack of knowledge about HCV that caused its fearful and stigmatizing attitude. "A lot of people fear the unknown," as one participant said when accounting for the stigma attached to hepatitis C. A 52-year-old Puerto Rican man referred to this notion of being seen as a vector of HCV infection, and his anticipation of discriminatory reactions from others, as follows:
Well, there I would say that the majority of the people think that the person who has hepatitis C is a danger; that's the first one. If they are aware that you have that kind of illness, what they do is that they exaggerate everything. If you go to eat in someone's home and they know you have that, the first thing is that they separate the plate and separate the spoon, no kisses on the lips, and be very careful, you know.
As the following quotation from a 54-year-old Puerto Rican man suggests, the participants' worry that their HCV seropositive status raises other peoples' anxiety about becoming infected and results in rejection was not unfounded:
They don't want to eat from the same bottle, or drink from the same bottle, or eat from the same spoon . . . well, anybody gets sick, that I, that I noticed, okay? People are very cold. I noticed it. I, uh, the majority of the people. If they're told, maybe, five or ten percent that don't feel that way. The participants' ignorance about HCV. The second factor that increased participants' apprehension about the highly contagious nature of HCV and their feelings of stigma was their own lack of information and understanding of this disease, which became apparent throughout the interviews. Numerous participants believed that HCV could be transmitted through sharing kitchen utensils or the toilet, by kissing, eating unclean food, drinking contaminated water, even touching someone or breathing into someone's face. Some participants confused the modes of transmission of hepatitis A and B with those of hepatitis C, and this heightened their sense of being contagious. These misconceptions about how easily HCV can be transmitted accounted for their acute concern about infecting others through casual contact, their descriptions of themselves as potential vectors of infection, and their acts of self-stigmatization and self-exile. For instance, a 51-year-old Puerto Rican woman, in discussing her fear of infecting her grandchildren with HCV, confessed that she did not know much about this disease, and saw it as a form of cancer:
I just try to be more careful, being I'm around my grandkids, you understand? Well, I take care of my body. I take care of any cuts that I have, you know, and I try to take care of myself individually, so that way I don't pass it on. I'm around my grandkids so much. . . . I don't know too much about hep C, if, you know, like the HIV, that you lose weight. I know it's like if you have cancer. And I have. My son had leukemia. I have a friend now that's in the hospital with cancer.
A 53-year-old African American woman who speculated that she became infected with HCV from "using drugs . . . or eating off other people's utensils," included "dirt, germs, and bacterias" that enter one's body "through the mouth" as possible modes of transmission. She believed HCV is very contagious, "because if the germ is spread, in, in and on the utensil, if somebody else already had it, and then, you using the utensil, I mean, I feel that it's easy to get." Her belief that HCV is transmitted through casual contact resulted in extensive disinfecting practices: I'm in my house by myself but, but I have, I am in the habit of, when I go to use my bathroom in the morning, and when I get up I spray it with a disinfectant. When I get through using it, I spray it with a disinfectant. And clean it. You know. And, I just got in the habit with that. When I go visit my daughter I always keep tissues or wipes and, I will wipe the toilet off behind me. Because, she has four boys, I mean, three boys and a little girl. . . . me and the boys use the bathroom. . . . I had to look out for those three children.
The description of herself as a "fanatic when it comes to Clorox [bleach]," and concealment of her HCV status from relatives to avoid being subjected to disinfecting rituals, reveal that she had internalized the HCV stigma:
[I have not told my relatives] 'cause, because, due to the fact that hepatitis C is more, uh, I mean, a germ and a bacteria that's picked up off of things. And then if I go to their house, and eat, you know, wondering when I leave, what are they doing, I mean, if they're running to get Clorox, to wash this down, to do that, because see, I experienced that with members of my family [because of my HIV status].
HCV and HIV are Equally Stigmatizing Because They Imply Drug Use
Although the majority of participants hierarchically ordered the stigmas of the two diseases, some claimed that both HIV and HCV are associated with drug use and socially marginalized groups, and therefore are equally stigmatizing. The same social stereotypes that exist for HIV and contribute to its discrediting nature were also perceived as relevant to the HCV disease. Participants believed that others blamed them for becoming infected with both diseases through their own illegal and irresponsible drug-using and sexually promiscuous behavior. For instance, a 56-yearold Puerto Rican woman attributed the intense stigma of both diseases to their preventable nature, and the illegal and morally discrediting behaviors associated with becoming infected. Her clear differentiation between those blameless individuals who acquired HIV through no fault of their own and the blameworthy who became infected through their own actions indicated her internalization of society's stereotypes:
Oh, a lot believe that, unless they were infected [with HIV] through transfusion or by a, um, a husband that was not very honest. The ones that are, that don't fit those categories, are dirty, are junkies, they pretty much, you know, deserve whatever they get, because they, they didn't take, they weren't very responsible with their lives or their family. So, I don't think they have too much sympathy for that population. Because HIV is something that could have been avoided, had, had the person been more responsible. . . . [I feel judged for being HIV infected]. Because it's an illness that could have been avoided. . . . [How do others judge] Me? Oh, even worse, because I'm a woman. I didn't get it through homosexuality, I got it through drug use. Those, no one forced me to use drugs. This was a choice I made. And then everything that goes with being a female drug abuser. If you have to support yourself, and even if you have a partner, you still have to bring in some money, because drugs are very expensive. You know, what you have to do to get the money. You have to steal, you have to prostitute yourself, you have to, um, cheat, lie-everything that's bad, you have to do.
Similarly, for HCV she referred to its preventable nature, and to poor choices that lead to infection and elicit negative judgments and reactions:
A lot of people believe it [HCV] comes from our drinking, just drinking. The mainstream, you know, population, you know, every time you have hepatitis C, they either think it's um, hepatitis, you know, what's the one with the yellow eyes? Jaundice. They either think it's jaundice, which comes, in most cases in the Bronx, from IV [intravenous] drug use, you know. Or they, if they don't believe that you got it that way, then they think right away, well, cirrhosis of the liver. Don't people that drink get that? . . . Yes [I think those with hepatitis C are looked down upon], just like HIV. Because, because they feel people have choices, and, and this is proof that you've made bad choices. If you were infected through a transmission, then you did it to yourself.
A 46-year-old Puerto Rican man also claimed that both diseases are equally stigmatizing because of their association with drug use and the accompanying lifestyle. He indicated that both HIV and HCV connote "dirt" and something "foul." At the time of the interview, he remained an active heroin user and had not disclosed either serostatus to his adult son: [HCV] , and so they think that they're better than, than the ones who do have it. [I have not told my son about either disease]; it's because of the dr-I never showed him drugs, or anything like that. You know, he was raised up without knowing that stuff, so for him to think that I was using, maybe he does know, maybe he doesn't. I don't, I don't know.
The concern mentioned above, that by revealing to his son his HIV and HCV serostatuses, the participant implicitly confessed to long-term drug use, and the accompanying lifestyle was a theme in several of the participants' stigma accounts. It often shaped their decision to conceal these diseases from their family, thus intensifying their sense of shame. Indeed, the association between drug use and being HCV seropositive, in particular, was so salient for some of the participants that it determined their disclosure patterns. For instance, they were more likely to disclose their HCV to their drug-using friends and acquaintances, because they perceived them as likely to also be infected, or at least understanding. As a 49-yearold African American woman stated, [I told my closest friends about my hepatitis C]. Because they, the majority of them was in a drug life. They not anymore, and stuff. I don't talk about my drug life. But they might have hepatitis C but not HIV.
In contrast, those who moved away from their drugusing networks refrained from disclosing their HCV for fear of being discredited as drug users. A 45-year-old Puerto Rican man explained that he had not disclosed his HCV status to any of his current friends because they lived a different lifestyle: After coming out of jail, he told some of his drug-using peers about his HIV status, further evidence that he was not concerned about being rejected by those who had shared the same lifestyle:
When I ran into them [people I used drugs with], I found out some of them aren't even alive any more, and the ones that are alive, I told them, "Listen yo, you, are you [HIV] positive? Because I'm positive." Some of them are, some of them aren't, or the ones that aren't, are saying that they're not.
Discussion
Our analysis revealed the multifaceted ways in which HIV/HCV-coinfected patients contended with having two stigmatizing diseases. Moreover, the participants' accounts of their perceptions and experiences of one disease's stigma in the presence of the other disease's stigma highlighted three themes that can inform the conceptualization of stigma. First, the value of distinguishing between what Goffman called "abominations of the body" and "blemishes of individual character" (Goffman, 1963, p. 4) for understanding the types and intensity of stigmas conferred by illnesses. Second, the importance of identifying the variety of ways in which enacted stigma has an impact on felt stigma, and allowing for targets of stigmatization to resist and/or negotiate feelings of stigma. Third, the significance of recognizing that the multiple layers of stigma do not have, by default, an additive or compounding effect on how people experience their multiple stigmatizing statuses. Instead, layers of stigma can interact in ways that mitigate a person's felt stigma, and lessen his or her exposure to enacted stigma.
Participants compared the stigmas conferred by each disease, and overwhelmingly perceived HIV as more stigmatizing than HCV. This hierarchical ordering of the two stigmas was associated with several factors, including their conceptualization of their HIV serostatus as a moral and social blemish on their character, and their HCV serostatus as a physical blemish. Participants attributed the stigmatizing potency of HIV and their feelings of shame and self-loathing to the stereotypical depiction of PLWHA as members of the socially despised groups of drug users, sex workers, and homosexuals who are blamed for becoming infected through deviant behaviors. In contrast, their discussions of HCV-related stigma focused on the embodied and contagious nature of the disease, and emphasized the multiple ways it can be transmitted. By representing hepatitis C as a disease that, apart from injecting drug use, can also be transmitted through innocuous everyday behaviors (e.g., sharing kitchen utensils or the toilet, consuming contaminated food or water), participants detached it from the deviant behavior of injecting drugs, thus promoting its normalization. Conceptualizing HCV as a "genuine disease" or "a malfunction of the liver" underscored its physical instead of its social feature, thus rendering it less stigmatizing than HIV. This finding that the interaction of the two diseases' stigmas severed the association of becoming HCV infected from the illegal and socially reprehensible behavior of injecting drugs is entirely novel. Moreover, this process of perceiving HCV stigma in the context of HIV stigma and vice versa explains why this study's coinfected sample attributed their HCV felt stigma primarily to its contagious nature, unlike the HCV-mono-infected samples of other studies that unequivocally identified the stereotypical perception that all HCV-infected persons are drug users as the primary source of their felt stigma and exposure to enacted stigma (Conrad et al., 2006; Crocket & Gifford, 2004; Golden et al., 2006; Harris, 2009 ).
In explaining why they felt more stigmatized for having HIV than HCV, participants also referred to their own and the public's perception of the former as a more deadly disease than the latter. As articulated in the HIV stigma literature, association of the disease with death challenges the public's existential denial of death, thus creating a reason for scapegoating and stigmatizing those infected (Gilmore & Somerville, 1994; Herek, 1999) . Although treatment advances have dramatically lowered the mortality rates of HIV and rendered it a more manageable chronic illness, its representation as a fatal illness persisted among our coinfected participants and contributed to their HIV felt stigma. Participants indicated that HIV continues to connote death, elicit dread, and thus, confer stigma. To substantiate the lethal nature of HIV, some emphasized its incurable nature, and others, by comparison, referred to the curable or simply less-serious nature of HCV disease. Conceptualizing HCV as potentially curable and less lethal than HIV increased the latter disease's stigmatizing potential. This finding highlights that the interface between the two diseases' representations that resulted in the participants' perception of HIV as incurable reproduced its image as a highly fatal disease and intensified its stigmatizing potency. Therefore, when designing interventions to destigmatize HIV or HCV, it is important to recognize that the perception of how fatal each disease is might differ among the HIV-mono-infected, the HCV-mono-infected, and the HIV/HCV-coinfected populations.
The third reason why participants regarded HIV stigma as more detrimental to their lives, their sense of self, and their well-being than HCV stigma was their exposure to interpersonal enacted stigmatization. Specifically, the demeaning rituals of excessive disinfection and segregation participants had been subjected to in the 1980s and 1990s, after disclosing their HIV serostatus fostered the perception of themselves as tainted and vectors of HIV infection, thus producing their feelings of profound shame and self-loathing. Based on their exposure to HIV-related hygienic degradation rituals, many participants anticipated subjection to similar HCV-related rituals. Their perception of HCV as a highly contagious disease and one that can be casually transmitted amplified their fears of exposure to degradation rituals, and partly accounted for their HCV felt stigma. To protect themselves from exposure to such rituals, many participants concealed their HCV status, at times socially isolating and engaging in selfstigmatizing practices, thus worsening their feelings of shame. The result of this emphasis on the infectious nature of HCV, by comparison, decreased the salience of the infectious nature of HIV. In the participants' accounts, infectivity was not the most prominent feature of HIV disease, nor was it discussed as the primary reason for their HIV felt stigma. Therefore, contending with two stigmatizing infectious diseases might increase or diminish the relative salience of each disease's infectious nature, thus changing the reason why carriers of multiple stigmatizing attributes experience stigma. In this sample, amplifying the infectious nature of HCV vis-à-vis HIV made contagiousness the primary source of HCV stigma.
In addition to the anticipated HCV degradation rituals, participants ascribed their feelings of HCV-related shame and fear of rejection to the casual ways in which this disease can be transmitted. Moreover, their perception of the public as ignorant about HCV, and their own ignorance about the disease, intensified their felt stigma and fear of infecting others and being ostracized. The finding that the participants' and the public's lack of HCV knowledge contributes to feelings of shame and anxiety about infecting others has been corroborated by studies on HCVmono-infected populations (Conrad et al., 2006; Crocket & Gifford, 2004) .
Our analysis of the interface between the HIV-and HCVrelated stigmas and their impact on felt stigma and exposure to enacted stigma revealed how individuals contend with having multiple stigmatizing attributes, and has the potential to further our understanding of stigma layering. Although researchers on HIV stigma layering have recognized that PLWHA "juggled a number of stigmatizing attributes and/or identities" (Ware et al., 2006, p. 908) , they have not identified the factors that influence this juggling act nor its outcomes. Similarly, researchers have identified the existence of HCV stigma layering and highlighted the significance of examining "the experience of stigmatization among those who are hepatitis C positive and have various attributes common to other stigmatized groups" (Paterson et al., 2007, p. 371 ), but they have not addressed how individuals perceive and manage multiple stigmas. The fact that HCV adds another layer to HIV stigma, and vice versa, has been largely overlooked in the stigma-layering literature. Moreover, researchers who have used the concept of stigma layering assumed an additive or compounding effect on the stigma experiences of the carriers of multiple stigmatizing attributes. The ways most participants contended with the stigmas of two highly discrediting, infectious, and behaviorally acquired diseases, however, suggested an interactive effect with multifaceted outcomes instead of an additive effect on felt stigma.
In our study, most participants hierarchically ordered the two stigmas, and although they perceived HIV as more stigmatizing than HCV, they also minimized HIV's contagiousness, thus decreasing the overall felt stigma associated with their coinfected status. Similarly, although they attributed their HCV felt stigma to the disease's highly contagious nature, they effectively severed the association of HCV from the discrediting behavior of injecting drug use, deflecting the blame of acquiring this disease through their own behavior, thus lessening the overall felt stigma associated with their coinfected status. In their discussions of how the HIV degradation rituals shaped their anticipation of similar HCV rituals, participants indicated how earlier experiences of enacted stigma because of one discrediting attribute had a formative effect on the management and felt stigma associated with a subsequent discrediting attribute. Therefore, future research on stigma layering will benefit from a comprehensive examination of how prior exposure to different forms of enacted stigmatization such as racism, sexism, and classism, shape individuals' experiences of HIV and HCV felt stigma and disclosure.
Although most coinfected patients hierarchically ordered the two stigmas and regarded HIV as the more stigmatizing disease, some did not differentiate between the two stigmas, and focused instead on their similarities. According to these participants, the feature shared by HIV and HCV, and the common source of their stigmatizing property, was that both diseases are behaviorally acquired through injecting drug use, a deviant and highly stigmatizing behavior that renders them blameworthy for becoming coinfected. In their stigma accounts, these participants discussed extensively their long-term drug use, and expressed intense feelings of guilt, regret, and shame about the deleterious effects of their drug-using lifestyle on their families and their own lives. Their strong feelings of stigma and self-loathing were based on their having internalized society's accusations of the drug-using lifestyle. These findings reveal that conceptualizing both diseases as the outcome of the same socially despised behavior (i.e., injecting drug use) prevented any differentiation between the stigmatizing potency of the two serostatuses, thus excluding the possibility of negotiating or resisting the stigmatizing potency of each disease's features and associated stereotypes. Homogenizing the source and intensity of the HIV and HCV stigmas seemed to result in participants experiencing the sum of the addition of two equally potent stigmas, thus increasing their overall felt stigma for being coinfected. For these participants, the two stigmas of HIV and HCV had a compounding effect.
Some limitations related to this study's sample must be addressed. All the participants were former or current injecting drug users, belonged to a racial/ethnic minority group, and overwhelmingly were socioeconomically disadvantaged. The lack of a subset of coinfected White, non-Hispanic, economically stable, non drug users limited our ability to engage in comparisons that might have elicited insights on how participants contended with the additional layers of stigma that stemmed from their race/ethnicity, social class, and drug-using status. However, despite having both men and women in the sample, female gender only sporadically emerged as a status contributing another layer of stigma. In accounting for this lack of gender difference, and considering the relative homogeneity of the sample, we propose that the salience of the stigmas associated with the two diseases that are contagious, acquired behaviorally, and serious might account for their overriding all other stigmatizing statuses. As PLWHA live longer and contend with other comorbidities, such as cancer, diabetes, or heart disease, that confer varied degrees of stigma, researchers will be able to examine how patients contend with the impact of different combinations of stigmatizing comorbidities on their felt and enacted stigma. This analysis of how coinfected patients perceived, felt about, and managed having two stigmatizing diseases has important implications for intervention design. For instance, campaigns focusing on destigmatizing injection drug use will have a more beneficial effect on coinfected individuals who attribute both HIV and HCV stigmas to this behavior. In contrast, individuals who associate HIV stigma to its disparaging impact on their character, and HCV stigma to its embodied and contagious nature, will benefit less from an intervention combating exclusively the opprobrium of IDU, and will require a program addressing misconceptions and concerns about HCV's highly infectious nature. As Reidpath & Chan (2005, p. 431) concluded, "there needs to be an understanding of the layering of [HIV] stigma so that informed policies and interventions can be developed that will address the entire experience of stigma." As the two epidemics of HIV and HCV continue to intersect, and the population of coinfected individuals increases, it becomes imperative to understand how they perceive, order, and contend with the two stigmas.
In this article, we have endeavored to enhance the conceptualization of the phenomenon of stigma layering by substantiating that individuals contending with multiple stigmatizing attributes actively engage in negotiating and even resisting the multiple layers of stigma. By comparing and hierarchically ordering the two diseases' stigmas, most participants influenced the intensity and source of each disease's stigma, thus diminishing the stigma of being coinfected. Therefore, we propose that the concept of stigma layering must be revisited and expanded to allow for the exploration of whether the multiple layers of stigmas conferred on individuals or groups have an interactive or compounding effect on their felt and enacted stigma.
